Wan Y - Search Results

1

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study.

Trudel S, Li Z, Dodgson C, Nanji S, Wan Y, Voralia M, Hitt M, Gauldie J, Graham FL, Stewart AK. Trudel S, et al. Among authors: wan y. Leukemia. 2001 May;15(5):846-54. doi: 10.1038/sj.leu.2402077. Leukemia. 2001. PMID: 11368448 Clinical Trial.

2

Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial.

Stewart AK, Lassam NJ, Quirt IC, Bailey DJ, Rotstein LE, Krajden M, Dessureault S, Gallinger S, Cappe D, Wan Y, Addison CL, Moen RC, Gauldie J, Graham FL. Stewart AK, et al. Among authors: wan y. Gene Ther. 1999 Mar;6(3):350-63. doi: 10.1038/sj.gt.3300833. Gene Ther. 1999. PMID: 10435085 Clinical Trial.

3

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.

Chen Y, Emtage P, Zhu Q, Foley R, Muller W, Hitt M, Gauldie J, Wan Y. Chen Y, et al. Among authors: wan y. Gene Ther. 2001 Feb;8(4):316-23. doi: 10.1038/sj.gt.3301396. Gene Ther. 2001. PMID: 11313806

4

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models.

Emtage PC, Wan Y, Hitt M, Graham FL, Muller WJ, Zlotnik A, Gauldie J. Emtage PC, et al. Among authors: wan y. Hum Gene Ther. 1999 Mar 20;10(5):697-709. doi: 10.1089/10430349950018463. Hum Gene Ther. 1999. PMID: 10210138

5

Intramarrow cytokine gene transfer by adenoviral vectors in dogs.

Foley R, Ellis R, Walker I, Wan Y, Carter R, Boyle M, Braciak T, Addison C, Graham F, Gauldie J. Foley R, et al. Among authors: wan y. Hum Gene Ther. 1997 Mar 20;8(5):545-53. doi: 10.1089/hum.1997.8.5-545. Hum Gene Ther. 1997. PMID: 9095406

6

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination.

Wan Y, Bramson J, Carter R, Graham F, Gauldie J. Wan Y, et al. Hum Gene Ther. 1997 Jul 20;8(11):1355-63. doi: 10.1089/hum.1997.8.11-1355. Hum Gene Ther. 1997. PMID: 9295130

7

A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model.

Emtage PC, Wan Y, Bramson JL, Graham FL, Gauldie J. Emtage PC, et al. Among authors: wan y. J Immunol. 1998 Mar 1;160(5):2531-8. J Immunol. 1998. PMID: 9498799

8

Enhanced interleukin-2 gene transfer immunotherapy of breast cancer by coexpression of B7-1 and B7-2.

Emtage PC, Wan Y, Muller W, Graham FL, Gauldie J. Emtage PC, et al. Among authors: wan y. J Interferon Cytokine Res. 1998 Nov;18(11):927-37. doi: 10.1089/jir.1998.18.927. J Interferon Cytokine Res. 1998. PMID: 9858314

9

Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines.

Wan Y, Bramson J, Pilon A, Zhu Q, Gauldie J. Wan Y, et al. Cancer Res. 2000 Jun 15;60(12):3247-53. Cancer Res. 2000. PMID: 10866318

10

Murine dendritic cells transduced with an adenoviral vector expressing a defined tumor antigen can overcome anti-adenovirus neutralizing immunity and induce effective tumor regression.

Wan Y, Emtage P, Foley R, Carter R, Gauldie J. Wan Y, et al. Int J Oncol. 1999 Apr;14(4):771-6. doi: 10.3892/ijo.14.4.771. Int J Oncol. 1999. PMID: 10087328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,027 results

Search Page

Filters